PAPER Badiola N, Suárez-Calvet M, Lleó A
SEARCH RESULTS
331007 RESULTS
PAPER da Cruz E Silva OA, Henriques AG, Domingues SC, da Cruz E Silva EF
Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):720-6. PubMed: 20942790PAPER Xilouri M, Stefanis L
Autophagy in the central nervous system: implications for neurodegenerative disorders.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):701-19. PubMed: 20942791PAPER Borovecki F, Habek M
Development of novel genomic blood biomarkers for neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):669-78. PubMed: 20942794PAPER Attea P, Johns H
Confronting Alzheimer's disease and other dementias.
J Am Geriatr Soc. 2010 Aug;58(8):1587-90. PubMed: 20942873PAPER Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, Low PA, Lee VM, Trojanowski JQ
TDP-43 pathology occurs infrequently in multiple system atrophy.
Neuropathol Appl Neurobiol. 2011 Jun;37(4):358-65. PubMed: 20942898PAPER Coppedè F
Variants and polymorphisms of DNA base excision repair genes and Alzheimer's disease.
J Neurol Sci. 2011 Jan 15;300(1-2):200-1; author reply 201. PubMed: 20943235PAPER Członkowska A, Kurkowska-Jastrzębska I
Inflammation and gliosis in neurological diseases--clinical implications.
J Neuroimmunol. 2011 Feb;231(1-2):78-85. PubMed: 20943275PAPER Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L, Gomis R, Novials A
BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells.
Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E1087-95. PubMed: 20943756PAPER Vollmar P, Kullmann JS, Thilo B, Claussen MC, Rothhammer V, Jacobi H, Sellner J, Nessler S, Korn T, Hemmer B
Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
J Immunol. 2010 Nov 15;185(10):6338-47. PubMed: 20943998PAPER Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.
Neuropsychopharmacology. 2011 Feb;36(3):559-68. PubMed: 20944553PAPER Alagiakrishnan K
Galantamine in the treatment of minor depression with mild to moderate Alzheimer's dementia in an elderly woman.
Prim Care Companion J Clin Psychiatry. 2010;12(3) PubMed: 20944777PAPER Kwon KJ, Kim HJ, Shin CY, Han SH
Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways.
J Clin Neurol. 2010 Sep;6(3):127-37. PubMed: 20944813PAPER Wang XH, Yang W, Qi JS
[Glucagon-like peptide 1: a novel therapeutic strategy for Alzheimer's disease].
Sheng Li Xue Bao. 2010 Oct 25;62(5):398-406. PubMed: 20945041PAPER Spaan PE, Raaijmakers JG
Priming effects from young-old to very old age on a word-stem completion task: minimizing explicit contamination.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011 Jan;18(1):86-107. PubMed: 20945237Current Filters
No filters selected